Autoantibodies against glutamate receptor ε2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis

European Neurology

Volumn 58, Issue 3, 2007, Pages 152-158

  Kimura, A ^a   Sakurai, T ^a   Suzuki, Y ^a   Hayashi, Y ^a   Hozumi, I ^a   Watanabe, O ^b   Arimura, K ^b   Takahashi, Y ^c   Inuzuka, T ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

Author keywords

Autoantibody; Glutamate receptor 2 subunit; Immunotherapy; Limbic encephalitis; N methyl D aspartate glutamate receptor; Paraneoplastic syndrome

Indexed keywords

AUTOANTIBODY; CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PENTOBARBITAL; RECEPTOR SUBUNIT; STEROID;

ACUTE DISEASE; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTROENCEPHALOGRAM; ENCEPHALITIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOTHERAPY; LABORATORY TEST; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BRAIN; FEMALE; HUMANS; IMMUNOGLOBULIN M; LIMBIC ENCEPHALITIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; RECEPTORS, GLUTAMATE; RETROSPECTIVE STUDIES;

EID: 35348923515     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104716     Document Type: Article

References (32)

1. Dale RC, Church AJ, Surtees RA, Lees AJ, Adcock JE, Harding B, Neville BG, Giovannoni G: Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004;127:21-33.
2. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF, McNamara JO: Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-651.
3. 7-Acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology 2005;65:1802-1804.
4. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-1193.
5. Takahashi Y, Mori H, Mishina M, Watanabe M, Fujiwara T, Shimomura J, Aiba H, Miyajima T, Saito Y, Nezu A, Nishida H, Imai K, Sakaguchi N, Kondo N: Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 2003;61:891-896.
6. 2 (in Japanese). Rinsho Shinkeigaku 2005;45:657-662.
7. Takahashi Y: Infections as causative factors of epilepsy. Future Neurol 2006;1:291-302.
8. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M: Molecular diversity of the NMDA receptor channel. Nature 1992;358:36-41.
9. Mori H, Mishina M: Structure and function of the NMDA receptor channel. Neuropharmacology 1995;34:1219-1237.
10. 2 subunit mutant mice. Neuron 1996;16:333-344.
11. Tang Y, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ: Genetic enhancement of learning and memory in mice. Nature 1999;401:63-69.
12. Watanabe M, Inoue Y, Sakimura K, Mishina M: Developmental changes in distribution of the NMDA receptor channel subunit mRNAs in the brain. Neuroreport 1992;3:1138-1140.
13. + channels of peripheral nerves. Ann Neurol 1995;38:714-722.
14. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123:1481-1494.
15. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 2002;1:294-305.
16. Kinirons P, Fulton A, Keoghan M, Brennan P, Farrell MA, Moroney JT: Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody. Neurology 2003;61:1623-1624.
17. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Kilimann MW, Lennon VA: Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005;58:96-107.
18. Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P, Rosenfeld MR: Clinical analysis of anti-Ma2-associated encephalitis. Brain 2004;127:1831-1844.
19. Alamowitch S, Graus F, Uchuya M, Rene R, Bescansa E, Delattre JY: Limbic encephalitis and small cell lung cancer: clinical and immunological features. Brain 1997;120:923-928.
20. Inuzuka T: Limbic encephalitis: etiology, pathogenesis, diagnosis and therapy (in Japanese). Rinsho Shinkeigaku 2004;44:799-801.
21. Kusuhara T, Shoji H, Kaji M, Ayabe M, Hino H: Non-herpetic acute limbic encephalitis (in Japanese). Rinsho Shinkeigaku 1994;34:1083-1088.
22. Bien CG, Schulze-Bonhage A, Deckert M, Urbach H, Helmstaedter C, Grunwald T, Schaller C, Elger CE: Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy. Neurology 2000;55:1823-1828.
23. Asaoka K, Shoji H, Nishizaka S, Ayabe M, Abe T, Ohori N, Ichiyama T, Eizuru Y: Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings. Intern Med 2004;43:42-48.
24. Watanabe Y, Shimizu Y, Ooi S, Tanaka K, Inuzuka T, Nakashima K: Steroid-responsive limbic encephalitis. Intern Med 2003;42:428-432.
25. Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, Galetta SL, Dichter M, Alavi A, Rosenfeld MR, Dalmau J: Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005;128:1764-1777.
26. Mori M, Kuwabara S, Yoshiyama M, Kanesaka T, Ogata T, Hattori T: Successful immune treatment for non-paraneoplastic limbic encephalitis. J Neurol Sci 2002;201:85-88.
27. Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jackson M, Vincent A: Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-78.
28. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S: Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177-1182.
29. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J: Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-712.
30. Fauser S, Talazko J, Wagner K, Ziyeh S, Jarius S, Vincent A, Schulze-Bonhage A: FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology. Acta Neurol Scand 2005;111:338-343.
31. Pozo-Rosich P, Clover L, Saiz A, Vincent A, Graus F: Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 2003;54:530-533.
32. Vincent A, Bien CG: Temporal lobe seizures, amnesia and autoantibodies - Identifying a potentially reversible form of non-paraneoplastic limbic encephalitis. Epileptic Disord 2005;7:177-179.